4/A//SEC Filing
Loberg Philip Walden Jr 4/A
Accession 0000885590-11-000021
CIK 0000885590other
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 7:00 PM ET
Size
5.3 KB
Accession
0000885590-11-000021
Insider Transaction Report
Form 4/AAmended
Loberg Philip Walden Jr
EVP, Interim CFO
Transactions
- Award
Common Stock, no par value
2010-12-22+694→ 130,065 total
Footnotes (2)
- [F1]Represents dividend equivalents accrued on performanced bases restricted share units (PSUs) as a result of a dividend paid on the common stock of Valeant Pharmaceuticals International, Inc. on December 22, 2010.
- [F2]This amendment is being filed to correct the number of PSUs that were reported in the original filing.
Documents
Issuer
Valeant Pharmaceuticals International, Inc.
CIK 0000885590
Entity typeother
Related Parties
1- filerCIK 0001508799
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 7:00 PM ET
- Size
- 5.3 KB